FLAGSTAFF, Ariz., June 13, 2017 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control,
announced today that in an effort to ensure that the Company can
meet the rapidly increasing demand for their innovative new rodent
control technology, ContraPest, it has launched its second
manufacturing line in Flagstaff.
With the addition of this second line, the Company's existing
manufacturing capacity is expected to more than double.
"We continue to learn and improve, and have incorporated that
knowledge into this second line. We are confident that we will be
able to handle the anticipated increase in demand," said
Elissa Calloway, Vice President of
Manufacturing at SenesTech.
In order to utilize both manufacturing lines, SenesTech has
added additional staff in both manufacturing and quality
control.
"Delighting our customers is our primary focus. Our
increased capacity insures timely and uninterrupted delivery of
ContraPest," said Andrew Altman,
Chief Operating Officer.
About SenesTech
SenesTech has developed an innovative technology for managing
animal pest populations through fertility control as opposed to a
lethal approach.
The Company's first fertility control product,
ContraPest®, is marketed for use in controlling rat
infestations. ContraPest's novel technology and approach
targets the reproductive capabilities of both sexes, inducing egg
loss in female rodents and impairing sperm development in males.
Using proprietary bait stations, ContraPest is dispensed in a
highly palatable liquid formulation that promotes sustained
consumption by rodent communities. ContraPest is designed,
formulated and dispensed to be safe for handlers and non-target
species such as wildlife, livestock and pets, in a biodegradable
product. In contrast, the historical approach to managing rodent
pest populations, rodenticides, carries a high risk of
environmental contamination and the poisoning of non-target
animals, pets and children.
We believe our non-lethal approach, targeting reproduction, is
more humane, less harmful to the environment, and more effective in
providing a sustainable solution to pest infestations than
traditional lethal pest management methods. There is currently no
other non-lethal fertility control product approved by the Food and
Drug Administration (FDA), or the Environmental Protection Agency
(EPA), for the management of rodent populations. We believe
ContraPest® will establish a new paradigm in rodent
control, resulting in improved performance in rodent control over
rodenticides, without the negative environmental effects of
rodenticides. For more information visit the SenesTech
website at www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. All forward-looking statements contained in this press
release speak only as of the date on which they were made and are
based on management's assumptions and estimates as of such date. We
do not undertake any obligation to publicly update any
forward-looking statements, whether as a result of the receipt of
new information, the occurrence of future events or
otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc, 928-779-4143
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/senestech-launches-second-manufacturing-line-in-flagstaff-to-ensure-uninterrupted-demand-300472666.html
SOURCE SenesTech, Inc.